An industrial X-ray CT scan shows the internal design of the ResMed AirSense 10 AutoSet CPAP device used by millions of sleep ...
Led by CEO Harry Rowland, VahatiCor is developing the A-Flux coronary sinus reducer implant for coronary microvascular dysfunction.
BTIG analyst Ryan Zimmerman said while the increase in approvals is promising, longer decision times may have financial implications.
Brian Miller shares how he built his career, what it was like at Intuitive as the device developer grew, and advice for ...